Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-25T17:33:00.142Z Has data issue: false hasContentIssue false
  • English
  • Français

A Controlled Trial of Abreaction with Lysergic Acid Diethylamide (Lsd-25)

Published online by Cambridge University Press:  29 January 2018

J. T. Robinson ,
L. S. Davies ,
E. L. N. S. Sack  and
J. D. Morrissey
J. T. Robinson
Affiliation:
Roffey Park Rehabilitation Centre, Horsham, Sussex
L. S. Davies
Affiliation:
Roffey Park Rehabilitation Centre, Horsham, Sussex
E. L. N. S. Sack
Affiliation:
Roffey Park Rehabilitation Centre, Horsham, Sussex
J. D. Morrissey
Affiliation:
Graylingwell Hospital, Chichester, Sussex
Get access Rights & Permissions [Opens in a new window]

Extract

All who have used lysergic acid diethylamide (LSD-25) acclaim it as a valuable aid to psychotherapy, regarding it as a “deep” abreactive agent, in that in certain cases it erupts early traumatic experiences as far back as infancy, with appropriate emotional catharsis which is believed to be of considerable therapeutic benefit to the patient. It is also claimed that it facilitates and enhances the transference situation.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 109 , Issue 458 , January 1963 , pp. 46 - 53
Copyright
Copyright © Royal College of Psychiatrists, 1963 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cohen, S., Fishman, L., and Eisner, B. J. (1958). Amer. J. Psychiat., 115, 30–35.CrossRefGoogle Scholar
Cohen, S., Fishman, L., and Eisner, B. J. (1960). J. Nerv. Ment. Dis., 130, 30.CrossRefGoogle Scholar
Cutner, M. (1959). Psychiat. Quart., 33, 715.CrossRefGoogle Scholar
Feld, , Myron, , Goodman, , Joseph, , and Guido, John A. (1958) J. Nerv. Ment. Dis., 126, 176–83.CrossRefGoogle Scholar
Fischer, R. (1954). J. Ment. Sci., 100, 623.CrossRefGoogle Scholar
Garmany, G. (1953). Proc. Roy. Soc. Med., 46, 155.Google Scholar
Hordern, A. (1952). J. Ment. Sci., 98, 630.CrossRefGoogle Scholar
Lebovitz, B., Visotsky, H. M., and Ostfield, A. M. (1960). A.M.A. Arch. Gen. Psychiat., Vol. 2.Google Scholar
Lewis, D. J., and Bruce Sloane, R. (1958). J. Clinic. Exper. Psych. & Quart. Rev. Psychiat. Neurol., 19, 19–31.Google Scholar
Martin, A. J. (1957). Int. J. Soc. Psychiat., 3, No. 3.CrossRefGoogle Scholar
Peck, T. T. (1959). in The Use of LSD in Psychiatry. Josiah Macy Jr. Foundation.Google Scholar
Sandison, R. A., Spencer, A. W., and Whitelaw, J. W. A. (1954). J. Ment. Sci., 100, 508.CrossRefGoogle Scholar
Sandison, R. A., Spencer, A. W., and Whitelaw, J. W. A. (1959). Bulletin W.H.O., 21, 4–5.Google Scholar
Sargant, W., and Shorvon, H. J. (1945). Arch. Neurol. Psychiat., 54, 23.CrossRefGoogle Scholar
Savage, C. (1959). in The Use of LSD in Psychiatry. Josiah Macy Jr. Foundation.Google Scholar
Shorvon, H. J., and Sargant, W. (1947). J. Ment. Sci., 93, 705.Google Scholar
Shorvon, H. J., and Sargant, W. (1953). Proc. Roy. Soc. Med., 46, No. 3, 158.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.